Impact of Escitalopram on Sperm DNA Fragmentation

• Status: Recruiting
• Trial end date: 2021-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

Double-blind placebo-controlled randomized trial of daily escitalopram for 6 weeks in healthy men with normal semen analyses and no psychiatric history of depression, bipolar, mania or suicidal ideation. Hormone profiles, semen analysis, sperm DNA fragmentation, and sexual function will be measured at baseline, after 6 weeks of therapy, and 4 weeks after discontinuation of therapy (10 weeks into study).

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Weill Medical College of Cornell University
• Treatments: Citalopram; Dexetimide

Criteria

Inclusion Criteria:

• Normal semen analyses, or semen analyses with at least 5 million sperm

• Normal TUNEL value (<7%)

• Willing to engage in at least weekly sexual activity, with a partner or alone for the duration of the 10-week study

Exclusion Criteria:

• Azoospermia or severe oligospermia (<5million sperm per semen analysis)

• Presently attempting to conceive pregnancy

• Sexual dysfunction preventing ability to provide semen analysis throughout study or engage in weekly sexual activity

• Current psychiatric disorder including: bipolar, mania, depression, generalized anxiety, social phobia, panic attacks, obsessive compulsive disorder, and schizophrenia.

• Family history of bipolar disorder, or suicide (including 2nd degree relatives)

• Present use of psychotropic agents (prescription or herbal) or anticonvulsants

• Use of sleeping pills

• Alcohol consumption greater that 2oz/day

• Use of illicit drugs

• Inability to read, follow instructions or complete questionnaires in English.

• Use of hormonal medications in past 3 months (androgens, androgen blockade, anabolic steroids, estrogens, herbal)

• Use of medications to enhance sexual function

• History of chemotherapy or pelvic radiation

• Use of Monoamine Oxidase inhibitors (MAOi's) or tricyclic antidepressants (TCAs) within 14 days

• Liver disease